Anti-CD37 antibodies for chronic lymphocytic leukemia. - Wikidata - wikimedia - TriplyDB

Anti-CD37 antibodies for chronic lymphocytic leukemia.

Anti-CD37 antibodies for chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q34405641

about

Targeted Therapies in Adult B-Cell Malignancies Current and emerging monoclonal antibody treatments for chronic lymphocytic leukemia: state of the art.CD19xCD3 DART protein mediates human B-cell depletion in vivo in humanized BLT mice Randomized phase 2 study of otlertuzumab and bendamustine versus bendamustine in patients with relapsed chronic lymphocytic leukaemia.Promising therapies for the treatment of chronic lymphocytic leukemia.Emerging immunological drugs for chronic lymphocytic leukemia.Treatment of chronic lymphocytic leukemia with monoclonal antibodies, where are we heading?Emerging antibody-drug conjugates for treating lymphoid malignancies.Combination therapy with the type II anti-CD20 antibody obinutuzumab.Investigational therapies targeting CD37 for the treatment of B-cell lymphoid malignancies.

P2860

Q26783195-D2D6F70D-BA58-46DB-BB1D-D907F6E1F620 Q34440110-3D7BEEFF-BF1B-49CB-85AA-FF44A95919E3 Q36777155-099AD094-EADD-4959-9297-6C232772FE9E Q37663837-2EEEA212-0D0C-4397-A7D5-58924F525265 Q38366441-BCF7AF9B-C349-4B3E-B3CF-8C303E60A2E4 Q38543771-3DAFD207-9DEB-4838-A119-B5850AD88A84 Q38573785-BB84912C-9546-4F3C-A8E2-21369D338848 Q38632313-60399AE1-BCE4-45FE-AAA3-001AE9FE2BBE Q47898168-95943AE3-9FEF-46C7-94F6-A6A3EB94669B Q48541938-E9AA6911-D125-4DB8-8A4C-42BAD8682152

P2860

Anti-CD37 antibodies for chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q34405641

description

2014 nî lūn-bûn

@nan

2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@ast

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@en

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@nl

type

label

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@ast

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@en

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@nl

prefLabel

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@ast

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@en

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@nl

P1433

Q34405641-D5DAFF96-C92B-4538-B214-A3EEE57E016D

P1476

Q34405641-66036B59-F1C0-44EC-969D-8884F7657239

P2093

Q34405641-61B78AB4-5C03-4274-99A8-55A30A54EE96

Q34405641-653313E8-BBD1-459E-B3A1-2238F793D479

P2860

Q34405641-030769F8-FCF8-46BE-AB0C-618343F856E4

Q34405641-09E8F2A2-1B76-4FB7-B9E8-D0E4CEA46D84

Q34405641-180AA53C-BBC5-48E3-A5B2-9D95B9AFC124

Q34405641-19F941AD-3E95-4B1E-A3BF-57719359C0A1

Q34405641-29F5FEB6-079B-40B5-ACBF-A9487878895C

Q34405641-38B18C6C-481B-4D16-9EBD-DE2D09F40CF5

Q34405641-3D6E9883-1D7F-4103-9968-01AC2FDF9512

Q34405641-3D992BA1-F780-4105-B99F-426B8D9C6243

Q34405641-40249E99-6E6D-48F6-A64F-657364A0C34C

Q34405641-41036D3F-16CE-4EC9-B586-1940D909758D

P304

Q34405641-D55C4413-99B2-431F-9142-C11FFC6F9401

P31

Q34405641-5D1ABFF7-B05B-474E-A8E4-DC2878BA23C6

P356

Q34405641-45D795EE-E76E-4B6C-8A87-FCD8D3B1605E

P407

Q34405641-EDD83B2B-D536-4CFC-AB0D-3E964505F32B

P433

Q34405641-393619C7-E130-4B71-8CED-9855A7E07E57

P478

Q34405641-4D636D98-99FB-488E-B8B1-797469CD9A4C

P577

Q34405641-20319461-8BAB-412F-AC1A-CC3E6DC14C42

P698

Q34405641-84E49FF3-FAA2-42D4-9C31-4FA2F1276A09

P921

Q34405641-25B81591-1D60-4937-B846-AB551A0F1AE0

Q34405641-C0ADE86C-28A6-4221-8D69-E56C074B9FC5

Q34405641-F07A0816-FA8B-4381-BAA8-DB5C4DC5D8B5

P356

14712598.2014.890182

P1433

Expert Opinion on Biological Therapy

P1476

Anti-CD37 antibodies for chronic lymphocytic leukemia.

@en

P2093

Pawel Robak

http://www.w3.org/2001/XMLSchema#string

Tadeusz Robak

http://www.w3.org/2001/XMLSchema#string

P2860

Tetraspanin CD37 directly mediates transduction of survival and apoptotic signals

Rituximab: mechanism of action

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Specific tetraspanin functions

Targeting CD37-positive lymphoid malignancies with a novel engineered small modular immunopharmaceutical

The primary structure of the human leukocyte antigen CD37, a species homologue of the rat MRC OX-44 antigen

Systematic review of purine analog treatment for chronic lymphocytic leukemia: lessons for future trials

Cancer treatment and survivorship statistics, 2012

Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

A regulatory role for CD37 in T cell proliferation

P304

651-661

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2014.890182

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24555705

http://www.w3.org/2001/XMLSchema#string

P921